Loading...
Back
TLX
TLX
TELIX PHARMACEUTICALS LTD
(TLX)
2026 6-K
Follow
Summary
Share
Summary
Director Appointment
2 Apr '26
FDA Resubmission Update
16 Mar '26
Telix Study Results
10 Mar '26
Annual Report Filing
19 Feb '26
Marketing Authorization Sub...
18 Feb '26
New Drug Application
20 Jan '26
Telix Conference Announcement
12 Jan '26
Portfolio Update
22 Dec '25
Global Study Update
17 Dec '25
Patient Dosing Update
8 Dec '25
Financial Update
14 Oct '25
Announcement Summary
23 Sep '25
FDA Agreement Update
8 Sep '25
Regulatory Update
28 Aug '25
H1 2025 Results
20 Aug '25
Q2 Revenue Growth
22 Jul '25
Gozellix Code Approval
9 Jul '25
Investor Day Announcement
11 Jun '25
AGM Results 2025
21 May '25
Regulatory Update
28 Apr '25
Quarterly Earnings Report
22 Apr '25
AGM Notice Filed
17 Apr '25
Efficacy Update
17 Apr '25
Government Response
7 Apr '25
Director Appointment
3 Apr '25
FDA Approval Announcement
20 Mar '25
New Approval
18 Mar '25
Theranostic Acquisition
12 Mar '25
Share Sale Announcement
26 Feb '25
FDA Priority Review
26 Feb '25
Board Renewal Update
25 Feb '25
Currency Change
24 Feb '25
Financial Report Filing
21 Feb '25
UK Approval Announced
13 Feb '25
Asset Acquisition
31 Jan '25
Acquisition Completed
27 Jan '25
European Approval Received
16 Jan '25
Revenue Update
13 Jan '25
Acquisition Announcement
13 Jan '25
Regulatory Filing
30 Dec '24
Pipeline Expansion
19 Nov '24
Nasdaq Trading Start
14 Nov '24
External Links:
SEC
On April 2, 2026, Telix Pharmaceuticals Ltd announced the appointment of David Gill as a Non-Executive Director, which adds to their management team.
AI Assistant
Close
TELIX PHARMACEUTICALS LTD
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.